VSee Health exchanges $612K note for 941K shares and enters $25M ELOC

VSEE HEALTH, INC.

Exchanged $611,878.22 promissory note for 941,352 common shares; note cancelled.
Secured $25M equity line of credit (ELOC) via directed stock purchase agreement; 36-month term.
ELOC pricing: 96% of 10-day low VWAP (94% if price below $1.00); expanded purchase up to $5M.
Sales capped at 19.9% of outstanding shares; proceeds for working capital and corporate purposes.
Both transactions with accredited institutional investors; unregistered under Sections 3(a)(9) and 4(a)(2).

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

VSEE HEALTH, INC. issued 941,352 shares of common stock to accredited institutional investor for exchange of a certain promissory note, in the principal amount (including the original issue discount of $55,555.56) of $555,555.56 and with a current balance o.

Security: common stock
Shares: 941,352 shares
Purchaser: accredited institutional investor
Consideration: exchange of a certain promissory note, in the principal amount (including the original issue discount of $55,555.56) of $555,555.56 and with a current balance o

Exact text from the filing

On November 13, 2025, VSee Health, Inc. (the “ Company ”), entered into an exchange agreement (the “ Agreement ”) with an accredited institutional investor (the “ Holder ”), whereby the Holder agreed to exchange a certain promissory note, in the principal amount (including the original issue discount of $55,555.56) of $555,555.56 and with a current balance of $611,878.22, for 941,352 shares of the Company’s common stock, par value $0.0001 per share.

View on SEC.gov

Browse all equity issuances →

VSEE HEALTH, INC. filing history →

Source: SEC EDGAR

accession 0001185185-25-001763

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.